Trading Paradigm

Train and Develop Professional-Level Trading Skills

  • ARTICLES
  • FREE COURSE
  • TOP RATED
    • #1 Mindset Course
      • 2ndSkies Trading
    • #1 Funding Program
      • Topstep Futures
    • #1 Futures Broker
      • Edge Clear
    • #1 Stock Newsfeed
      • Benzinga Pro
    • #1 Stock Screener
      • Finviz
    • Recommended Books
  • FAQ
  • TRUTH/REALITIES
    • The Fantasy Gap
    • Proper Expectations
    • Knowledge vs. Skills
    • Entertainment vs. Training
    • Trading vs. Gambling
  • MINDSET/PSYCHOLOGY
    • Natural Biases
    • The Mirror Concept
    • Self-Transformation
    • Failure is Feedback
    • More Mindset Articles
  • EDGE/EXPECTED VALUE
    • Market Methodology
    • Expected Value Formula
    • Asymmetric Risk-Reward
    • Trade Tracking & Review
    • More Edge Articles
  • FREE RESOURCES
  • FREE COURSE: TRADING SUCCESS FRAMEWORK → GET STARTED BECOMING A REAL TRADER

6/1 Watch List (Matt Thomas) – Managing 5 Open Positions

May 31, 2017 By Matt Thomas Leave a Comment


My Open Positions as of Wednesday, 5/31:

I started scaling into both biotech stocks discussed in Last Week’s Watch List – CYTX and ITEK. In addition to that, I still own shares of ROX and LQMT from My 5/15 Watch List. To round out my five open positions, I entered GRPN this past week as well.

Ticker Number of Shares Average Price
CYTX 250 $1.00
ITEK 450 $1.70
ROX 1250 $1.67
LQMT 682 $0.27
GRPN 150 $3.15

Here’s a detailed breakdown of my open positions:

CYTX (Cytori Therapeutics, Inc.)

Thesis: With a solid base forming in the $0.90-1.00 range, I expect the upcoming July catalyst to drive shares up over $1.10 within the next month or so. That catalyst is phase 3 data for Scleroderma. From a technical standpoint, there’s also a nice gap to recover in the $1.20-1.30 region. [Link to Catalyst]

Price at Close 5/31: $1.00
Buy Zone: $.90-1.00
Disclosure: Currently Own 250 Shares at $1.00

CYTX Chart

ITEK (Inotek Pharmaceuticals Corporation)

Thesis: I see a base forming in the $1.60-1.75 region, so I expect the share price to trend upwards as the mid-2017 catalyst approaches – phase 2 data for Glaucoma. Just like CYTX, I’m anticipating a run-up to occur between now and then. There’s a huge gap to close up to $6.00, but it all starts with a break of $2.00. [Link to Catalyst]

Price at Close 5/31: $1.70
Buy Zone: $1.60-1.75
Disclosure: Currently Own 450 Shares at $1.70

ITEK Chart

ROX (Castle Brands Inc.)

Thesis: This stock has continued it’s uptrend since appearing on my 5/15 watch list. My buy zone then was in the $1.70’s, but I don’t foresee it retreating back down to that level in the near term. I took some more profits as it broke into the $2.00’s on 5/25. It’s now consolidating in the $1.90’s and hopefully gearing up for another move deeper into the $2.00’s. A recent contract with Walmart and a potential buyout are the main reasons I’m drawn to this stock right now.

Price at Close 5/31: $1.95
Buy Zone: $1.85-1.90
Disclosure: Currently Own 1,250 Shares at $1.67

ROX Chart

LQMT (Liquidmetal Technologies Inc.)

Thesis: With solid support at $0.25, I really like the risk/reward ratio on this one. Not only can iPhone rumors send this one flying (which has happened on multiple occassions in the past), but if their technology is actually used on the next iPhone, there’s no guessing how high the share price might go. In addition to that, the CEO appears to be strategically positioning them in the medical device industry and has a solid track record of turning companies into technological leaders.

Price at Close 5/31: $0.29
Buy Zone: $0.25-0.27
Disclosure: Currently Own 682 Shares at $0.27

LQMT Chart

GRPN (Groupon, Inc.)

Thesis: I think this stock has buyout potential, especially in the eyes of Alibaba. The possibility of this has been brought up multiple times in the past, but haven’t heard much about it lately. Maybe these rumors will start swirling again, or better yet, an actual takeover. I started scaling into this trade, but didn’t necessarily like the price action today. I’d really like to see this hold $3.00 (or close to it) through the end of the week. I’ll be keeping a tight leash on it if it continues to drop.

Price at Close 5/31: $3.01
Buy Zone: $2.95-3.00
Disclosure: Currently Own 150 Shares at $3.15

GRPN Chart

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. PLEASE REFER TO DISCLAIMER.

Filed Under: Matt Thomas Watch List

TRADING SUCCESS FRAMEWORK (FREE COURSE)

SEARCH

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

TRADING SUCCESS FRAMEWORK (FREE COURSE)

SEARCH

#1 Beginner Learning Program

Thomas Kralow Trading Academy - University Grade Trading Education

Read Full Thomas Kralow Review

#1 Trading Psychology Course

2ndSkies Trading With Chris Capre

Read Full 2ndSkies Trading Review

#1 Funded Futures Trader Program

Topstep Trader - Top Funded Futures Trading Program

Read Full Topstep Trader Review

#1 Stock Market Newsfeed

Benzinga Pro - Top Rated Stock Market Newsfeed

Read Full Benzinga Pro Review

#1 Futures Brokerage Service

What is EdgeClear - Is it the Best Broker to Trade Futures With?

Read Full Edge Clear Review

#1 Stock Screener Tool

Finviz and Finviz Elite - Top Rated Stock Screener

Read Full Finviz Elite Review

Risk Disclaimer||Affiliate Disclosure||Privacy Policy||Site Map||Contact||About